For people aged 18-29, only 1% had ever used GLP-1 drugs to treat chronic conditions, while 7% of those in this age group had used them for weight loss, and a further 3% had used them for chronic conditions and weight loss
The Wegovy pill is approved in the UK and available privately
However: It is still under investigation Long term data is not yet complete Approval and availability are not guaranteed For now, Ozempic and other licensed treatments remain the established clinical options in the UK
In rare cases where someone seems to metabolize semaglutide much faster or slower than average, providers might adjust timing between doses, but this is unusual
Rapid weight loss can lead to water loss, and if you feel dizzy or get leg cramps, youre probably low on electrolytes, he says